FIELD: medicine, laboratory diagnostics.
SUBSTANCE: before prescribing quetiapin, it is necessary to conduct immunological studying in patients and at the content of natural killers (CD16+)0.15x109/l and more, IgA concentration in blood serum being 2.50 g/l and less one should predict positive dynamics of therapy with atypical neuroleptic quetiapin (seroquel). The innovation enables to elaborate prognostic criteria for therapeutic efficiency in schizophrenia-suffering patients with atypical neuroleptic quetiapin (seroquel) and carry out rehabilitation of pharmacological measures purposefully.
EFFECT: higher accuracy and efficiency of prediction.
3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
| METHOD OF TREATING PATIENTS WITH SCHIZOPRENIA | 2009 |
|
RU2415666C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
| METHOD OF EFFICIENCY FORECAST FOR RESIDUAL SHIZOPHRENIA TREATMENT BY ATYPICAL NEUROLEPTIC QUETIAPINE | 2007 |
|
RU2349918C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
| PREDICTION METHOD OF THERAPY EFFECTIVENESS IN PATIENTS WITH PAROXYSMAL SCHIZOPHRENIA | 2016 |
|
RU2621266C1 |
| METHOD FOR PREDICTING INFRINGEMENTS IN COMPLIANCE WITH THERAPY FOR FURTHER CORRECTION OF PATIENTS WITH SCIZOPHRENIA | 2016 |
|
RU2611934C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF VISCERAL OBESITY IN PATIENTS WITH SCHIZOPHRENIA RECEIVING QUETIAPINE THERAPY | 2017 |
|
RU2659638C1 |
